# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-26T13:19:49.230059

---

**Idea Fidelity**

The paper stays close to the manifest idea. It leverages the QWI Race-Hispanic panel, focuses on NAICS 62 (healthcare) versus Manufacturing placebo, constructs a triple-difference (ULR × Black × Healthcare) estimator, and uses staggered adoption with Callaway–Sant’Anna event studies. Key elements—identifying ULR states 2019–2021, focusing on the Black-White earnings gap, and validating via placebo and robustness checks—are present. The manifest’s emphasis on whether licensing portability narrows the racial gap in healthcare wages remains front and center.

**Summary**

The paper asks whether Universal Licensing Recognition (ULR) laws narrow the Black-White earnings gap in healthcare, exploiting staggered adoption across eleven states and comparing healthcare to manufacturing using the Census QWI Race-Hispanic panel. A well-specified triple-difference and supporting Callaway–Sant’Anna estimates show no statistically or economically meaningful impact of ULR on the racial wage gap, with clean pre-trends and robust null results across various checks. The paper concludes that while ULR may affect aggregate mobility, it does not differentially help Black healthcare workers catch up to their White counterparts.

**Essential Points**

1. **Power and Precision of Null Finding**  
   The paper claims a precise null but relies on relatively short post-treatment windows (2–3 years for most states). The null could reflect insufficient time to observe mobility-induced wage convergence. Please provide a more formal discussion of detectable effect sizes conditional on the variance in the treated group, perhaps with a power calculation tailored to the staggered DDD design. Without this, it is hard to interpret the null as ruling out a meaningful policy impact, especially if mobility and matching respond slowly.

2. **Validity of the Manufacturing Placebo**  
   Manufacturing is treated as a placebo industry, yet it is subject to its own labor market shocks (trade policy, automation, COVID exposure) that may differentially affect Black and White workers across states. Since the identifying assumption is that only healthcare reacts to ULR-induced mobility changes, any differential manufacturing shocks that correlate with ULR adoption could bias the DDD. Please provide evidence that manufacturing Black-White gaps do not move systematically around ULR adoptions (e.g., placebo event study, pre-trend tests for the manufacturing D×Black gap) or consider an industry less likely to share external shocks with ULR states.

3. **Interpreting the Az-only Pre-COVID Result**  
   The Arizona-only specification yields a small but statistically significant widening of the gap, yet the main interpretation treats it as a null. This raises the question of heterogeneous effects across waves. The paper mentions longer-term positive effects in Callaway-Sant’Anna but does not reconcile them with the Arizona result or wave-specific trends. Please explore heterogeneity explicitly (e.g., by adoption wave or by state characteristics such as existing reciprocity regimes) and clarify whether the Arizona evidence undermines the “no effect” conclusion or suggests effect heterogeneity that ought to be part of the narrative.

**Suggestions**

1. **Strengthen the Discussion of Parallel Trends**  
   The event study is helpful, yet the narrative would benefit from directly plotting the pre-treatment Black-White gap in healthcare and manufacturing for treated and control states to visually confirm the triple-difference parallelism. Adding these plots (with confidence intervals) would make the identifying assumption more transparent to readers unfamiliar with the design.

2. **Add More Institutional Detail on ULR Exposure for Healthcare Occupations**  
   The paper states that ULR covers all licensed professions, but it would be useful to quantify the share of Black healthcare workers holding licenses that require state re-examination. Are certain sub-occupations (e.g., RNs versus aides) more affected? Even if occupational detail is not in QWI, citing external sources or matching to licensure data could reinforce why this policy is expected to matter for Black healthcare wages.

3. **Clarify the Role of COVID in the Event Study**  
   The quarter-by-race-by-industry fixed effects soak up national COVID shocks, but the pandemic’s disproportionate state-level impact could still coincide with ULR timing (especially the 2020–2021 adopters). Consider showing that COVID case or mortality trajectories in ULR states are not systematically different around adoption dates, or alternatively include state-specific COVID controls (e.g., hospitalization rates, mobility measures). This would bolster confidence that COVID-related shocks do not bias the post-treatment window.

4. **Decompose the DDD Gap into Shares and Wages**  
   The earnings gap can result from compositional changes (shifts in occupation mix) or wage changes within occupations. While the paper’s administrative data do not allow within-occupation analysis, you might proxy this by decomposing the gap using available variables (e.g., average employment shares of major sub-industries within NAICS 62 if available). This could help determine whether ULR affects the composition (e.g., attracting different occupations) even if average wages are unchanged.

5. **Discuss Policy Implications More Fully**  
   The conclusion rightly tempers expectations about ULR addressing racial gaps, but policymakers might read the null as implying ULR is irrelevant for racial equity. It would be helpful to elaborate on alternative complementary policies (e.g., targeted credential portability programs, within-state equity efforts) and to suggest how ULR evaluations could be paired with such initiatives to create equitable outcomes.

6. **Consider Alternative Weighting Schemes**  
   The main specification weights by employment, which emphasizes large states. It might be informative to show results from a per-capita or unweighted specification that treats each state equally, as ULR’s racial effects might manifest differently in smaller states with different racial compositions. Table 4 already reports an unweighted robustness check, but expanding this to include a discussion (why results are similar, what it implies) would help readers understand the generalizability of the results.

7. **Engage More With Heterogeneous Treatment Effects Literature**  
   The paper smartly uses Callaway–Sant’Anna, but the discussion could go further in interpreting the event-study dynamics by wave. The Appendix table hints at wave-specific SDEs; consider bringing a short summary into the main paper, explaining why wave 1 and wave 3 estimates differ and what that says about timing, COVID, or structural differences across states.

8. **Report Effect Sizes in Levels for Intuition**  
   While log points are standard, translating the 0.005 estimate into dollars (or stating what a 2.7% bound corresponds to in monthly earnings) would help readers grasp the magnitude of the null. This is particularly useful when presenting confidence intervals that “rule out effects larger than 2.7%” — anchoring that percentage to, say, a typical Black healthcare worker’s earnings adds interpretive clarity.

9. **Elaborate on Treatment Variation and First Stage**  
   Since DDD relies on the idea that ULR affects healthcare wages via mobility, provide any direct evidence that ULR actually increased interstate healthcare employment flows in the data (e.g., increases in out-of-state hires, employment growth in high-demand occupations). Even if the focus is on wage gaps, such evidence strengthens the claim that the policy was operative and that the null is not due to no treatment effect at all.

These additions would increase the credibility of the null finding, clarify the institutional scope, and enrich the policy discussion, making the paper a stronger contribution to the occupational licensing and racial wage gap literatures.
